A. Lawrence

发表

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma

Naveena Singh, P. Chakravarty, I. McNeish, 2016, Clinical Cancer Research.

Polycystic Ovarian Syndrome and Gynaecological Cancer

A. Lawrence, W. Mason, 2009 .

Treatment of Advanced Stage Ovarian Cancer

J. Butler, A. Lawrence, 2014 .

Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)

N. Bizzarri, P. Ramirez, R. Manchanda, 2022, International Journal of Gynecological Cancer.

Persistence of fimbrial tissue on the ovarian surface after salpingectomy

D. Oram, A. Jeyarajah, R. Manchanda, 2017, American journal of obstetrics and gynecology.

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

D. Evans, R. Legood, G. Burghel, 2021, Cancers.

British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)

J. Ledermann, C. Fotopoulou, P. Martin-Hirsch, 2020, International Journal of Gynecological Cancer.

Outcomes of Adjuvant Chemoradiation and Predictors of Survival After Extended Cholecystectomy in Gall Bladder Carcinoma: a Single Institution Experience from an Endemic Region

N. Kumari, R. Saxena, N. Rastogi, 2015, Journal of Gastrointestinal Cancer.

Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum?

R. Wuntakal, A. Lawrence, 2013, Medical hypotheses.

The use of novel tumour markers and statistical models in the preoperative diagnosis of ovarian cancer

A. Lawrence, 2008 .

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma

P. Chakravarty, I. McNeish, F. Balkwill, 2016, Clinical Cancer Research.